OVERSEA CHINESE BANKING Corp Ltd Has $224,000 Holdings in DocuSign, Inc. (NASDAQ:DOCU)

OVERSEA CHINESE BANKING Corp Ltd cut its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU) by 52.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,496 shares of the company’s stock after selling 2,766 shares during the period. OVERSEA CHINESE BANKING Corp Ltd’s holdings in DocuSign were worth $224,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Kestra Investment Management LLC acquired a new position in DocuSign during the 4th quarter valued at about $30,000. First Horizon Advisors Inc. lifted its position in DocuSign by 102.6% during the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after purchasing an additional 201 shares during the period. Modus Advisors LLC acquired a new stake in shares of DocuSign in the 4th quarter valued at approximately $36,000. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign in the 3rd quarter valued at approximately $28,000. Finally, Avion Wealth raised its position in shares of DocuSign by 309.2% in the 4th quarter. Avion Wealth now owns 487 shares of the company’s stock valued at $43,000 after acquiring an additional 368 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at DocuSign

In other news, CEO Allan C. Thygesen sold 40,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the transaction, the chief executive officer now directly owns 156,050 shares of the company’s stock, valued at $14,050,742. This trade represents a 20.40 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now directly owns 8,270 shares of the company’s stock, valued at $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 97,851 shares of company stock valued at $8,579,369 in the last ninety days. 1.66% of the stock is currently owned by corporate insiders.

DocuSign Stock Down 0.6 %

Shares of DOCU opened at $85.11 on Friday. The stock has a market capitalization of $17.19 billion, a P/E ratio of 17.55, a P/E/G ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The company has a 50 day moving average of $87.58 and a 200-day moving average of $79.95.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million during the quarter, compared to analysts’ expectations of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business’s quarterly revenue was up 9.0% on a year-over-year basis. During the same period last year, the business earned $0.76 EPS. On average, sell-side analysts anticipate that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on DOCU. William Blair upgraded shares of DocuSign from a “market perform” rating to an “outperform” rating in a research report on Monday. Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. JPMorgan Chase & Co. upgraded shares of DocuSign from an “underweight” rating to a “neutral” rating and increased their price target for the company from $70.00 to $75.00 in a research report on Monday, March 10th. UBS Group cut their price target on shares of DocuSign from $100.00 to $90.00 and set a “neutral” rating on the stock in a research report on Friday, March 14th. Finally, HSBC reiterated a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $95.00.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.